To provide for the establishment of the Task Force on Research Specific to Pregnant Women and Lactating Women, to require an annual report to Congress on approved new drug applications with information on pregnancy and lactation, and for other purposes.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for Washington's 3rd congressional district. Republican.
Last Updated: May 12, 2016
Length: 9 pages
May 12, 2016
114th Congress, 2015–2017
Died in a previous Congress
This bill was introduced on May 12, 2016, in a previous session of Congress, but was not enacted.
What stakeholders are saying
May 12, 2016
H.R. 5219 (114th) was a bill in the United States Congress.
How to cite this information.
Civic Impulse. (2018). H.R. 5219 — 114th Congress: Safe Medications for Moms and Babies Act of 2016. Retrieved from https://www.govtrack.us/congress/bills/114/hr5219
“H.R. 5219 — 114th Congress: Safe Medications for Moms and Babies Act of 2016.” www.GovTrack.us. 2016. February 23, 2018 <https://www.govtrack.us/congress/bills/114/hr5219>
|title=H.R. 5219 (114th)
|accessdate=February 23, 2018
|author=114th Congress (2016)
|date=May 12, 2016
|quote=Safe Medications for Moms and Babies Act of 2016